These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7882823)

  • 1. Enhanced pressor responsiveness to norepinephrine in type II diabetes. Effect of ACE inhibition.
    Ciavarella A; Mustacchio A; Ricci C; Capelli M; Vannini P
    Diabetes Care; 1994 Dec; 17(12):1484-7. PubMed ID: 7882823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibition in diabetic patients: effect on pressor responsiveness to noradrenaline.
    Strocchi E; Malini PL; Ciavarella A; Valtancoli G; Ricci C; Mustacchio A; Vannini P; Ambrosioni E
    J Hum Hypertens; 1992 Aug; 6(4):317-9. PubMed ID: 1433167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
    Hoogenberg K; Navis G; Dullaart RP
    Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
    Uehlinger DE; Ferrier CP; Matthieu R; Reuter K; Gnaedinger MP; Saxenhofer H; Shaw S; Weidmann P
    J Hypertens; 1989 Nov; 7(11):901-7. PubMed ID: 2558135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
    de Leeuw PW; Birkenhäger WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S26-9. PubMed ID: 2422490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
    Malini PL; Strocchi E; Valtancoli G; Ambrosioni E
    J Clin Pharmacol; 1990 May; 30(5):422-4. PubMed ID: 2161435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term norepinephrine infusion on plasma catecholamines, renin, and aldosterone in normal and hypertensive man.
    Beretta-Piccoli C; Weidmann P; Meier A; Grimm M; Keusch G; Glück Z
    Hypertension; 1980; 2(5):623-30. PubMed ID: 6998868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
    Hollenberg NK; Fisher ND; Price DA; Williams GH
    Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.
    Bianchetti MG; Weidmann P; Beretta-Piccoli C; Ferrier C
    Kidney Int; 1987 Apr; 31(4):956-63. PubMed ID: 3586502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ace inhibition on peripheral hemodynamics in normotensive and hypertensive patients with type II diabetes.
    Strocchi E; Malini PL; Ciavarella A; Ricci C; Valtancoli G; Mustacchio A; Vannini P; Ambrosioni E
    J Clin Pharmacol; 1991 Feb; 31(2):140-3. PubMed ID: 2010559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological effects of short-term treatment with enalapril in hypertensive patients.
    de Leeuw PW; Hoogma RP; van Soest GA; van Es PN; Birkenhäger WH
    J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular pressor responses in treated and untreated essential hypertension.
    Donnelly R; Elliott HL; Howie CA; Sumner DJ; Reid JL
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):191-6. PubMed ID: 1697373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy].
    Andronico G; Carone MB; Mulè G; Mangano MT; Cerasola G
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1161-4. PubMed ID: 2100527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril versus combined enalapril and nadolol treatment: effects on blood pressure, heart rate, humoral variables, and plasma potassium at rest and during exercise in hypertensive patients.
    Sullivan PA; Daly B; O'Connor R
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):261-5. PubMed ID: 1637731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.